D‐cycloserine‐augmented one‐session treatment of specific phobias in children and adolescents

BACKGROUND: D‐Cycloserine has potential to enhance exposure therapy outcomes. The current study presents a preliminary randomized, placebo‐controlled double‐blind pilot trial of DCS‐augmented one‐session treatment (OST) for youth (7–14 years) with specific phobia. A secondary aim of this pilot study...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Brain Behav
Auteurs principaux: Farrell, Lara J., Waters, Allison M., Oar, Ella L., Tiralongo, Evelin, Garbharran, Vinay, Alston‐Knox, Clair, McConnell, Harry, Collings, Nigel, Zimmer‐Gembeck, Melanie, Donovan, Caroline L., Testa, Chris, Storch, Eric A., Ollendick, Thomas H.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5991588/
https://ncbi.nlm.nih.gov/pubmed/30106248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.984
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires